Delivery Order SPE2DR25D2205-SPE2DR26F1P55
- Not listed
- On December 10, 2025, the Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical supply. This firm fixed price contract, which is not set-aside, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of XDEMVY 0.25% DROP 10ML pharmaceutical product. This firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by October 16, 2025. The contract is being performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters, and does not utilize a set-aside designation. As a child contract, this...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be delivered to the company's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for pharmaceutical supplies valued at $1,223.59. The contract covers XDEMVY 0.25% DROP 10ML, a specialized pharmaceutical product, with an ultimate completion date of August 27, 2025. The award was made through a competitive process with no set-aside designation and utilizes firm fixed pricing. This delivery order will be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for pharmaceutical supplies totaling $1,184.60 with a firm fixed price. The specific product is XDEMVY 0.25% Drop in 10ml format, which will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 2, 2026. This is a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical product, with a firm fixed price structure and no set-aside designation. The award was issued on November 12, 2025, with an ultimate completion date of December 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1P55Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical products, with a ceiling value of $1,184.60 under a firm fixed price contract. The delivery order, classified as a child contract, is set to be completed by January 7, 2026, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitive procurement action, consistent with AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to fulfill federal medical supply requirements through competitive procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/14/25 |